期刊文献+

hCAP-18/LL-37基因转染对RAW264.7细胞活化功能的影响

Effect of hCAP-18/LL-37 Gene Transfection on Activation of RAW264.7 Cells
原文传递
导出
摘要 目的探讨抗菌肽hCAP-18/LL-37基因转染对巨噬细胞RAW264.7活化功能的影响。方法将重组质粒pcD-NA4/Myc-His-hCAP-18/LL-37瞬时转染RAW264.7细胞,MTT法检测细胞的增殖活性;中性红吞噬试验检测细胞的吞噬能力;RT-PCR法分析细胞活化相关分子CD80、CD86、TLR4及细胞因子IL-1β、TNF-αmRNA的转录。结果 hCAP-18/LL-37基因转染可促进经脂多糖(Lipopolysaccharide,LPS)处理的RAW264.7细胞的增殖活性与吞噬能力(P<0.05);可上调RAW264.7细胞CD80、CD86、TLR4、IL-1β、TNF-α基因mRNA的转录水平。结论 hCAP-18/LL-37基因转染可通过促进RAW264.7细胞增殖活性、吞噬能力及活化相关分子表达,调控巨噬细胞的活化功能。 Objective To investigate the effect of hCAP-18 / LL-37 gene transfection on the activation of macrophage RAW 264.7.Methods RAW264.7 cells were transiently transfected with recombinant plasmid pcDNA4 / Myc-His-hCAP-18 / LL-37,then determined for proliferation activity by MTT method,for phagocytosis ability by neutral red phagocytosis test,and for transcriptions of mRNAs of cell activation-related molecules CD80,CD86 and TLR4 as well as cytokines IL-1β and TNF-α.Results The transfection with hCAP-18 / LL-37 gene enhanced the proliferation activity and phagocytosis ability of RAW264.7 cells after treatment with lipopolysaccharide(LPS)(P 0.05),and up-regulated the transcriptions of CD80,CD86,TLR4,IL-1β and TNF-α mRNAs.Conclusion The transfection with hCAP-18 / LL-37 gene regulated the activation of macrophage by enhancing the proliferation activity and phagocytosis ability of RAW264.7 cells as well as the expressions of activation-related molecules.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第2期153-156,共4页 Chinese Journal of Biologicals
基金 吉林省自然科学基金项目(201015194)
关键词 抗菌肽 hCAP-18/LL-37 转染 巨噬细胞 活化 脂多糖类 Antibacterial peptide hCAP-18 / LL-37 Transfection Macrophage Activation Lipopolysaccharides
  • 相关文献

参考文献12

  • 1Barlow PG, Li Y, Wilkinson TS, et al. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system [J]. J Leukoc Biol, 2006, 80 (3): 509-520.
  • 2Howell MD, Wollenberg A, Gallo RL, et al. Cathelicidin deficiency predisposes to eczema herpeticum [J]. J Allergy Clin Immunol, 2006, 117 (4) : 836-841.
  • 3Heilbom JD, Nilsson MF, Kratz G, et al. The eathelieidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium [J]. J Invest Dermatol, 2003, 120 (3): 379-389.
  • 4Akashi-Takamura S, Miyake K. Toll-like receptors(TLRs) and immune disorders [J]. J Infect Chemother, 2006, 12 (5): 233-240.
  • 5Koczulla R, Von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 [J]. J Clin Invest, 2003, 111 (11): 1665-1672.
  • 6Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a laetoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties [J]. Cell Mol Life Sci, 2005, 62 (22): 2588-2598.
  • 7袁红艳,许娜,王凤丽,常雅萍.hCAP-18/LL-37全长肽真核表达产物对树突状细胞分化成熟的影响[J].中国实验诊断学,2010,14(3):346-348. 被引量:1
  • 8袁红艳,王凤丽,许娜,常雅萍.真核表达hCAP-18/LL-37成熟肽对树突状细胞表面分子表达的影响[J].吉林大学学报(医学版),2009,35(3):482-486. 被引量:1
  • 9Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases [J]. Inflammopharmacology, 2007, 15 (6): 252-259.
  • 10Rivas-Santiago B, Hemandez-Pando R, Carranza C, et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells [J]. Infect Immun, 2008, 76 (3): 935-941.

二级参考文献14

  • 1Kai-Larsen Y, Agerberth B. The role of the multifunctional peptide LL-37 in host defense [J]. Front Biosci, 2008, 13 (10): 3760-3767.
  • 2Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications [J]. Curr Opin Hematol, 2009, 16 (1): 41-47.
  • 3Niyonsaba F, Ushio H, Nakano N, et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines [J]. J Invest Dermatol, 2007, 127 (3): 594-604.
  • 4Carretero M, Escamez MJ, Garcia M, et al. In vitro and in vivo wound healing promoting activities of human cathelicidin LL-37 [J]. J Invest Dermatol, 2008, 128 (1): 223-236.
  • 5Malmsten M, Davoudi M, Walse B, et al. Antimicrobial peptides derived from growth factors [J]. Growth Factors, 2007, 25 (1): 60-70.
  • 6Bandholtz L, Ekman GJ, Vilhelmsson M, et al. Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype[J]. Scand J Immunol, 2006, 63 (6): 410-419.
  • 7Starner TD, Agerberth B, Gudmundsson GH, et al. Expression and activity of beta-defensins and LL-37 in the developing human lung [J]. J Immunol, 2005, 174 (3): 1608-1615
  • 8Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelieidin family of antimierobial peptides [J]. Biochim Biophys Acta, 2006, 1758 (9): 1408-1425.
  • 9Barlow P G, Y Li, Wilkinson T S, et al. The hnman cationic host defense peptide LL-37 mediates contrasting effects on apoptotie pathways in different primary cells of the innate immune system[ J]. J Leukoc Biol, 2006,80 (3) :509.
  • 10Niyonsaba F A, Someya M, Hirata, et al. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells[J]. Eur J Immunol, 2001,31 (4) :1066.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部